-
Loading metrics
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
-
Tiffany C. Chang ,
Contributed equally to this work with: Tiffany C. Chang, Margarite D. Matossian
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
* E-mail: tchang10@tulane.edu (TCC); bcollin1@tulane.edu (BMCB)
Affiliations Department of Medicine, Section of Hematology/Oncology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America, Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, United States of America
⨯ - Margarite D. Matossian ,
- Steven Elliott,
- Hope E. Burks,
- Rachel A. Sabol,
- Deniz A. Ucar,
- Henri Wathieu,
- Jovanny Zabaleta,
- Luis De Valle,
- Sukhmani Gill,
- Elizabeth Martin,
- Adam I. Riker,
- Lucio Miele,
- Bruce A. Bunnell,
- Matthew E. Burow,
- [ ... ],
- Bridgette M. Collins-Burow
- [ view all ]
- [ view less ]
http://orcid.org/0000-0002-0468-7546
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
- Tiffany C. Chang,
- Margarite D. Matossian,
- Steven Elliott,
- Hope E. Burks,
- Rachel A. Sabol,
- Deniz A. Ucar,
- Henri Wathieu,
- Jovanny Zabaleta,
- Luis De Valle,
- Sukhmani Gill
x
- Published: October 9, 2020
- https://doi.org/10.1371/journal.pone.0226464